Neutrolis

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

1. January 2021 – November 2026 · 9 captures · latest observed messagingTargeting the ‍ Dark Side of DNA

   This wording observed 6 November 2026.

   current websiteHistorical capture not publicly available
   Inspect 9 captures in this group

   • 28 January 2021 · Neutrolis - Targeting the Dark Side of DNA archived page
   • 5 August 2021 · Neutrolis - Targeting the Dark Side of DNA archived page
   • 5 July 2022 · Neutrolis - Targeting the Dark Side of DNA archived page
   • 30 January 2023 · Neutrolis - Targeting the Dark Side of DNA archived page
   • 19 July 2024 · Targeting the ‍ Dark Side of DNA archived page
   • 1 January 2025 · Targeting the ‍ Dark Side of DNA archived page
   • 17 January 2026 · Targeting the ‍ Dark Side of DNA archived page
   • 13 July 2026 · Targeting the ‍ Dark Side of DNA archived page
   • 6 November 2026 · Targeting the ‍ Dark Side of DNA current websiteHistorical capture not publicly available
2. August 2018 – July 2019 · 2 capturesUntangling Inflammation

   Neutrolis is a preclinical drug discovery company focusing on treating inflammatory diseases with unmet needs. Neutrolis uses a proprietary genetic technology platform to identify disease mechanisms a

   This wording observed 21 July 2019.

   archived page
   Inspect 2 captures in this group

   • 20 August 2018 · Untangling Inflammation archived page
   • 21 July 2019 · Untangling Inflammation archived page